Fig. 3From: Development of a novel BRCAness score that predicts response to PARP inhibitorsHallmark GSEA of high BRCAness in breast cancer. Enrichment analysis of gene signaling pathways which have significant difference between low and high BRCAness consistently in three cohorts; TCGA, METABRIC, and GSE96058 cohorts. The top tertile was used as cutoff to divide high- or low- BRCAness groups. FDR, false discovery rate; NES, normalized enrichment scoreBack to article page